David Steel - Small Pharma Chief Officer
| DMTTFDelisted Stock | USD 0.05 0.0009 1.80% |
Insider
David Steel is Chief Officer of Small Pharma
| Phone | 44 2071 129118 |
| Web | https://www.smallpharma.com |
Small Pharma Management Efficiency
The company has return on total asset (ROA) of (0.4124) % which means that it has lost $0.4124 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7826) %, meaning that it generated substantial loss on money invested by shareholders. Small Pharma's management efficiency ratios could be used to measure how well Small Pharma manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Valerie Cros | Cellectis SA | N/A | |
| Gerry Arambula | Covalon Technologies | N/A | |
| Simon Smith | Covalon Technologies | N/A | |
| Jean Epinat | Cellectis SA | N/A | |
| Marvin MD | Mosaic Immunoengineering | 79 | |
| Paul CPA | Mosaic Immunoengineering | 55 | |
| MSc MSc | Cellectis SA | 54 | |
| Mark Doolittle | Covalon Technologies | N/A | |
| Greg Leszczynski | Covalon Technologies | N/A | |
| Pascalyne Wilson | Cellectis SA | N/A | |
| Joseph MPH | Mosaic Immunoengineering | 50 | |
| Cyril Empig | Mosaic Immunoengineering | N/A | |
| Elaine Zhang | Covalon Technologies | N/A | |
| Jay Carlson | Mosaic Immunoengineering | N/A | |
| Ron Hebert | Covalon Technologies | N/A | |
| Hamed Abbasian | Covalon Technologies | N/A | |
| Nicole Steinmetz | Mosaic Immunoengineering | 43 | |
| Dr MBA | Cellectis SA | 46 | |
| Steven King | Mosaic Immunoengineering | 59 | |
| Jason Gorel | Covalon Technologies | N/A | |
| Kyung NamWortman | Cellectis SA | 53 | |
Management Performance
| Return On Equity | -0.78 | |||
| Return On Asset | -0.41 |
Small Pharma Leadership Team
Elected by the shareholders, the Small Pharma's board of directors comprises two types of representatives: Small Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Small. The board's role is to monitor Small Pharma's management team and ensure that shareholders' interests are well served. Small Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Small Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sarah Hamilton, Group Controller | ||
| LLB HBA, Co Sec | ||
| George Tziras, CEO Director | ||
| David Steel, Chief Officer | ||
| Peter Rands, Founder Officer | ||
| Carol Routledge, Chief Officer | ||
| MD MSc, Chief Officer | ||
| Jenny Maguire, Head Communications | ||
| Emma Hodge, Head Property | ||
| Marie Layzell, Chief Director |
Small Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Small Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.78 | |||
| Return On Asset | -0.41 | |||
| Current Valuation | 24.67 M | |||
| Shares Outstanding | 321.56 M | |||
| Shares Owned By Insiders | 31.08 % | |||
| Shares Owned By Institutions | 3.00 % | |||
| Price To Book | 1.15 X | |||
| Price To Sales | 69,846 X | |||
| Gross Profit | 45 K | |||
| EBITDA | (22.47 M) |
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Small OTC Stock
If you are still planning to invest in Small Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Small Pharma's history and understand the potential risks before investing.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |